HeraMED Ltd Reinstated to ASX Quotation
Key points
- Trading suspension lifted after lodgement of quarterly reports
- Announcement of material capital raising
- Resumption of trading from 5 August 2025
Full summary
HeraMED Limited (ASX: HMD) has been reinstated to quotation on the Australian Securities Exchange (ASX) effective from the commencement of trading on 5 August 2025. The company's securities were previously suspended from trading pending the lodgement of its quarterly activity report and quarterly cash flow report for the quarter ended 30 June 2025, as well as an announcement in relation to a material capital raising. With the required reports now lodged and the capital raising announcement made, the suspension of trading in HeraMED's securities has been lifted, allowing the company's shares to resume trading on the ASX.
Summary generated by a large language model. Please interpret with care.